Immune checkpoint inhibitors increase risk of neurological disorders

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2021年 / 1838卷 / 1期
关键词：
D O I：
10.1007/s40278-021-89325-7
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：6 / 6
相关论文
共 50 条
  • [41] How to diagnose and manage neurological toxicities of immune checkpoint inhibitors: an update
    Vogrig, Alberto
    Muniz-Castrillo, Sergio
    Farina, Antonio
    Honnorat, Jerome
    Joubert, Bastien
    JOURNAL OF NEUROLOGY, 2022, 269 (03) : 1701 - 1714
  • [42] NEUROLOGICAL ADVERSE EVENTS ASSOCIATED WITH THE IMMUNE CHECKPOINT INHIBITORS: REVIEW OF THE LITERATURE AND CHARACTERIZATION OF THE NEUROLOGICAL PATTERNS
    Cuzzubbo, S.
    Tissier, M.
    Barlog, C.
    Doridam, J.
    Ursu, R.
    Belin, C.
    Carpentier, A. F.
    NEURO-ONCOLOGY, 2016, 18 : 25 - 26
  • [43] Tyrosine kinase inhibitors and immune checkpoint inhibitors-induced thyroid disorders
    Jannin, Arnaud
    Penel, Nicolas
    Ladsous, Miriam
    Vantyghem, Marie Christine
    Do Cao, Christine
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 141 : 23 - 35
  • [44] Autoimmune Movement Disorders Complicating Treatment with Immune Checkpoint Inhibitors
    Dinoto, Alessandro
    Trentinaglia, Milena
    Carta, Sara
    Mantovani, Elisa
    Ferrari, Sergio
    Tamburin, Stefano
    Tinazzi, Michele
    Mariotto, Sara
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2024, 11 (05): : 543 - 549
  • [45] Safety of immune checkpoint inhibitors in patients with preexisting autoimmune disorders
    Kumar, Rohit
    Chan, Abigail
    Bandikatla, Sudeepthi
    Ranjan, Smita
    Ngo, Phuong
    CURRENT PROBLEMS IN CANCER, 2022, 46 (04)
  • [46] Immune Checkpoint Inhibitors Before Liver Transplantation May Increase the Risk of Rejection: A Meta-Analysis
    Moeckli, B.
    Toso, C.
    Wassmer, C. H.
    El Hajji, S.
    Kumar, R.
    Lacotte, S.
    Compagnon, P.
    BRITISH JOURNAL OF SURGERY, 2024, 111 : III19 - III19
  • [47] Immune checkpoint inhibitors increase the risk of kidney transplant rejection: a real-world pharmacovigilance study
    Wu, Junyan
    Huang, Jianxiang
    Zhu, Jianhong
    He, Zhichao
    Chen, Mengting
    Gao, Siyuan
    Liang, Dan
    Yu, Xiaoxia
    Lu, Chengyu
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (03) : 231 - 235
  • [48] Risk of pneumonitis with different immune checkpoint inhibitors in NSCLC
    Shohdy, Kyrillus S.
    Abdel-Rahman, Omar
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (17)
  • [49] Immune Checkpoint Inhibitors and Risk of Type 1 Diabetes
    Chen, Xuan
    Affinati, Alison H.
    Lee, Yungchun
    Turcu, Adina F.
    Henry, Norah Lynn
    Schiopu, Elena
    Qin, Angel
    Othus, Megan
    Clauw, Dan
    Ramnath, Nithya
    Zhao, Lili
    DIABETES CARE, 2022, 45 (05) : 1170 - 1176
  • [50] Immune checkpoint inhibitors: risk of severe cardiovascular events
    Reactions Weekly, 2018, 1729 (1) : 7 - 7
12345